Skip to main content
SpringerLink
Log in

Lipid Mediators in the Regulation of Emotions, Memory, and Cognitive Functions

  • Chapter
  • First Online:
Book cover Endocannabinoids and Lipid Mediators in Brain Functions

Abstract

This chapter aims at highlighting the diverse roles of endocannabinoids in the coordination of balanced neuronal activities, which finally set the basis for the organism’s characteristics to store and remember important and useful things, to forget non-useful things, and to cope with new challenges. Altogether, the fine-tuned regulation of these processes is crucial for optimal life and survival. The endocannabinoid system appears to be a central intrinsic homeostatic factor in the organism, modulating these processes. Receptors for (endo)cannabinoids are also targets for exogenous cannabinoids, putting also relevance of external substances in the interference with these processes. The genetic dissection of the endocannabinoid system together with the many pharmacological, biochemical, behavioral, and electrophysiological approaches has led to relevant insights into this lipid signaling system in the regulation of emotions, memory, and cognitive functions. Recent progresses are discussed in this chapter, particularly the question on cell type- and region-specific involvements of endocannabinoids and the CB1 receptor-dependent regulation of distinct neuronal pathways in the context of fear behaviors and stress-induced effects on memory formation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bellocchio L, Soria-Gomez E, Quarta C, Metna-Laurent M, Cardinal P, Binder E, Cannich A, Delamarre A, Haring M, Martin-Fontecha M, Vega D, Leste-Lasserre T, Bartsch D, Monory K, Lutz B, Chaouloff F, Pagotto U, Guzman M, Cota D, Marsicano G (2013) Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB(1) receptor blockade. Proc Natl Acad Sci U S A 110:4786–4791

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bloomfield MA, Ashok AH, Volkow ND, Howes OD (2016) The effects of Delta9-tetrahydrocannabinol on the dopamine system. Nature 539:369–377

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Busquets-Garcia A, Gomis-Gonzalez M, Srivastava RK, Cutando L, Ortega-Alvaro A, Ruehle S, Remmers F, Bindila L, Bellocchio L, Marsicano G, Lutz B, Maldonado R, Ozaita A (2016) Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation. Proc Natl Acad Sci U S A 113:9904–9909

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cheng Y, Dong Z, Liu S (2014) beta-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARgamma pathway. Pharmacology 94:1–12

    Article  CAS  PubMed  Google Scholar 

  • Davis M, Walker DL, Miles L, Grillon C (2010) Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 35:105–135

    Article  PubMed  Google Scholar 

  • de Quervain D, Schwabe L, Roozendaal B (2017) Stress, glucocorticoids and memory: implications for treating fear-related disorders. Nat Rev Neurosci 18:7–19

    Article  PubMed  Google Scholar 

  • Dincheva I, Drysdale AT, Hartley CA, Johnson DC, Jing D, King EC, Ra S, Gray JM, Yang R, DeGruccio AM, Huang C, Cravatt BF, Glatt CE, Hill MN, Casey BJ, Lee FS (2015) FAAH genetic variation enhances fronto-amygdala function in mouse and human. Nat Commun 6:6395

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Do Monte FH, Souza RR, Bitencourt RM, Kroon JA, Takahashi RN (2013) Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptors. Behav Brain Res 250:23–27

    Article  PubMed  Google Scholar 

  • Dubreucq S, Matias I, Cardinal P, Haring M, Lutz B, Marsicano G, Chaouloff F (2012) Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice. Neuropsychopharmacology 37:1885–1900

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Garcia-Gutierrez MS, Ortega-Alvaro A, Busquets-Garcia A, Perez-Ortiz JM, Caltana L, Ricatti MJ, Brusco A, Maldonado R, Manzanares J (2013) Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors. Neuropharmacology 73:388–396

    Article  CAS  PubMed  Google Scholar 

  • Gazarini L, Stern CA, Carobrez AP, Bertoglio LJ (2013) Enhanced noradrenergic activity potentiates fear memory consolidation and reconsolidation by differentially recruiting alpha1- and beta-adrenergic receptors. Learn Mem 20:210–219

    Article  CAS  PubMed  Google Scholar 

  • Gray JM, Vecchiarelli HA, Morena M, Lee TT, Hermanson DJ, Kim AB, McLaughlin RJ, Hassan KI, Kuhne C, Wotjak CT, Deussing JM, Patel S, Hill MN (2015) Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety. J Neurosci 35:3879–3892

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gunduz-Cinar O, Hill MN, McEwen BS, Holmes A (2013) Amygdala FAAH and anandamide: mediating protection and recovery from stress. Trends Pharmacol Sci 34:637–644

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gunduz-Cinar O, Flynn S, Brockway E, Kaugars K, Baldi R, Ramikie TS, Cinar R, Kunos G, Patel S, Holmes A (2016) Fluoxetine facilitates fear extinction through amygdala endocannabinoids. Neuropsychopharmacology 41:1598–1609

    Article  CAS  PubMed  Google Scholar 

  • Hartley ND, Gunduz-Cinar O, Halladay L, Bukalo O, Holmes A, Patel S (2016) 2-arachidonoylglycerol signaling impairs short-term fear extinction. Transl Psychiatry 6:e749

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hill MN, Kumar SA, Filipski SB, Iverson M, Stuhr KL, Keith JM, Cravatt BF, Hillard CJ, Chattarji S, McEwen BS (2013) Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. Mol Psychiatry 18:1125–1135

    Article  CAS  PubMed  Google Scholar 

  • Jacob W, Marsch R, Marsicano G, Lutz B, Wotjak CT (2012) Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo. Neurobiol Learn Mem 98:47–55

    Article  CAS  PubMed  Google Scholar 

  • Jenniches I, Ternes S, Albayram O, Otte DM, Bach K, Bindila L, Michel K, Lutz B, Bilkei-Gorzo A, Zimmer A (2016) Anxiety, stress, and fear response in mice with reduced endocannabinoid levels. Biol Psychiatry 79:858–868

    Article  CAS  PubMed  Google Scholar 

  • Jurkus R, Day HL, Guimaraes FS, Lee JL, Bertoglio LJ, Stevenson CW (2016) Cannabidiol regulation of learned fear: implications for treating anxiety-related disorders. Front Pharmacol 7:454

    Article  PubMed  PubMed Central  Google Scholar 

  • Kamprath K, Romo-Parra H, Haring M, Gaburro S, Doengi M, Lutz B, Pape HC (2011) Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdala. Neuropsychopharmacology 36:652–663

    Article  CAS  PubMed  Google Scholar 

  • Karpova NN, Pickenhagen A, Lindholm J, Tiraboschi E, Kulesskaya N, Agustsdottir A, Antila H, Popova D, Akamine Y, Bahi A, Sullivan R, Hen R, Drew LJ, Castren E (2011) Fear erasure in mice requires synergy between antidepressant drugs and extinction training. Science 334:1731–1734

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kishimoto Y, Cagniard B, Yamazaki M, Nakayama J, Sakimura K, Kirino Y, Kano M (2015) Task-specific enhancement of hippocampus-dependent learning in mice deficient in monoacylglycerol lipase, the major hydrolyzing enzyme of the endocannabinoid 2-arachidonoylglycerol. Front Behav Neurosci 9:134

    Article  PubMed  PubMed Central  Google Scholar 

  • Lange MD, Daldrup T, Remmers F, Szkudlarek HJ, Lesting J, Guggenhuber S, Ruehle S, Jungling K, Seidenbecher T, Lutz B, Pape HC (2016) Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat. Mol Psychiatry. doi:10.1038/mp.2016.156

    PubMed Central  Google Scholar 

  • Laricchiuta D, Centonze D, Petrosini L (2013) Effects of endocannabinoid and endovanilloid systems on aversive memory extinction. Behav Brain Res 256:101–107

    Article  CAS  PubMed  Google Scholar 

  • Li Y, Kim J (2015) Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus. Neuroscience 311:253–267

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li Y, Kim J (2016a) CB2 Cannabinoid receptor knockout in mice impairs contextual long-term memory and enhances spatial working memory. Neural Plast 2016:9817089

    PubMed  Google Scholar 

  • Li Y, Kim J (2016b) Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus. Hippocampus 26:275–281

    Article  CAS  PubMed  Google Scholar 

  • Llorente-Berzal A, Terzian AL, Di Marzo V, Micale V, Viveros MP, Wotjak CT (2015) 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons. Psychopharmacology (Berl) 232:2811–2825

    Article  CAS  Google Scholar 

  • Lomazzo E, Bindila L, Remmers F, Lerner R, Schwitter C, Hoheisel U, Lutz B (2015) Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain. Neuropsychopharmacology 40:488–501

    Article  CAS  PubMed  Google Scholar 

  • Luksys G, Sandi C (2011) Neural mechanisms and computations underlying stress effects on learning and memory. Curr Opin Neurobiol 21:502–508

    Article  CAS  PubMed  Google Scholar 

  • Lutz B, Marsicano G, Maldonado R, Hillard CJ (2015) The endocannabinoid system in guarding against fear, anxiety and stress. Nat Rev Neurosci 16:705–718

    Article  CAS  PubMed  Google Scholar 

  • Maccarrone M, Guzman M, Mackie K, Doherty P, Harkany T (2014) Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. Nat Rev Neurosci 15:786–801

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgansberger W, Di Marzo V, Lutz B (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418:530–534

    Article  CAS  PubMed  Google Scholar 

  • Mizrachi Zer-Aviv T, Segev A, Akirav I (2016) Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention. Behav Pharmacol 27:561–569

    Article  CAS  PubMed  Google Scholar 

  • Morena M, Campolongo P (2014) The endocannabinoid system: an emotional buffer in the modulation of memory function. Neurobiol Learn Mem 112:30–43

    Article  CAS  PubMed  Google Scholar 

  • Morena M, Patel S, Bains JS, Hill MN (2016) Neurobiological interactions between stress and the endocannabinoid system. Neuropsychopharmacology 41:80–102

    Article  CAS  PubMed  Google Scholar 

  • Norris C, Loureiro M, Kramar C, Zunder J, Renard J, Rushlow W, Laviolette SR (2016) Cannabidiol modulates fear memory formation through interactions with serotonergic transmission in the mesolimbic system. Neuropsychopharmacology 41:2839–2850

    Article  CAS  PubMed  Google Scholar 

  • Platt RJ et al (2014) CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159:440–455

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Puente N, Cui Y, Lassalle O, Lafourcade M, Georges F, Venance L, Grandes P, Manzoni OJ (2011) Polymodal activation of the endocannabinoid system in the extended amygdala. Nat Neurosci 14:1542–1547

    Article  CAS  PubMed  Google Scholar 

  • Qin Z, Zhou X, Pandey NR, Vecchiarelli HA, Stewart CA, Zhang X, Lagace DC, Brunel JM, Beique JC, Stewart AF, Hill MN, Chen HH (2015) Chronic stress induces anxiety via an amygdalar intracellular cascade that impairs endocannabinoid signaling. Neuron 85:1319–1331

    Article  CAS  PubMed  Google Scholar 

  • Ramikie TS, Nyilas R, Bluett RJ, Gamble-George JC, Hartley ND, Mackie K, Watanabe M, Katona I, Patel S (2014) Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses. Neuron 81:1111–1125

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Remmers F, Lange MD, Hamann M, Ruehle S, Pape HC, Lutz B (2017) Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions through conditional genetic rescue in forebrain GABAergic neurons. Brain Struct Funct. doi:10.1007/s00429-017-1411-5

  • Ruehle S, Remmers F, Romo-Parra H, Massa F, Wickert M, Wortge S, Haring M, Kaiser N, Marsicano G, Pape HC, Lutz B (2013) Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: distinctive sufficiency for hippocampus-dependent and amygdala-dependent synaptic and behavioral functions. J Neurosci 33:10264–10277

    Article  CAS  PubMed  Google Scholar 

  • Seidenbecher T, Remmes J, Daldrup T, Lesting J, Pape HC (2016) Distinct state anxiety after predictable and unpredictable fear training in mice. Behav Brain Res 304:20–23

    Article  PubMed  Google Scholar 

  • Singewald N, Schmuckermair C, Whittle N, Holmes A, Ressler KJ (2015) Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders. Pharmacol Ther 149:150–190

    Article  CAS  PubMed  Google Scholar 

  • Soltesz I, Alger BE, Kano M, Lee SH, Lovinger DM, Ohno-Shosaku T, Watanabe M (2015) Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy. Nat Rev Neurosci 16:264–277

    Article  CAS  PubMed  Google Scholar 

  • Song C, Stevenson CW, Guimaraes FS, Lee JL (2016) Bidirectional effects of cannabidiol on contextual fear memory extinction. Front Pharmacol 7:493

    PubMed  PubMed Central  Google Scholar 

  • Soria-Gomez E, Busquets-Garcia A, Hu F, Mehidi A, Cannich A, Roux L, Louit I, Alonso L, Wiesner T, Georges F, Verrier D, Vincent P, Ferreira G, Luo M, Marsicano G (2015) Habenular CB1 receptors control the expression of aversive memories. Neuron 88:306–313

    Article  CAS  PubMed  Google Scholar 

  • Stempel AV, Stumpf A, Zhang HY, Ozdogan T, Pannasch U, Theis AK, Otte DM, Wojtalla A, Racz I, Ponomarenko A, Xi ZX, Zimmer A, Schmitz D (2016) Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the hippocampus. Neuron 90:795–809

    Article  CAS  PubMed  Google Scholar 

  • Tovote P, Fadok JP, Luthi A (2015) Neuronal circuits for fear and anxiety. Nat Rev Neurosci 16:317–331

    Article  CAS  PubMed  Google Scholar 

  • Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, Bloomfield MA, Curran HV, Baler R (2016) Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiat 73:292–297

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University, Duesbergweg 6, 55128, Mainz, Germany

    Beat Lutz

Authors
  1. Beat Lutz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Beat Lutz .

Editor information

Editors and Affiliations

  1. Dept Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy

    Miriam Melis

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Lutz, B. (2017). Lipid Mediators in the Regulation of Emotions, Memory, and Cognitive Functions. In: Melis, M. (eds) Endocannabinoids and Lipid Mediators in Brain Functions. Springer, Cham. https://doi.org/10.1007/978-3-319-57371-7_6

Download citation

Publish with us

Policies and ethics

Search

Navigation